Flow cytometry analysis examined the change in CD45+ cells (leukocytes), CD45+CD8+ cells (CTLs), CD45+CD4+ cells (T helper cells), and CD45+CD4+Foxp3+ cells (Tregs) in tumours both 3 and 7 days after the initial treatment day. Here, PTPRC is linked to neoplasm.